2025-04-08 17:56:59
Latest Post
Godrej Properties delivers its highest ever quarterly and full year bookings
Poonawalla Fincorp Launches Shopkeeper Loan Business
Revolt Motors Expands to 200 Dealerships, Targets 400 by FY26
Sobha Ltd - Real Estate Operational Update - Q4 FY 2024-25
Lemon Tree Hotels signs a new property in DarjeelingStock Report
Biogen Pharmachem Industries Ltd Q3FY23 profit at Rs. 30.13 lakhs
Posted On : 2023-02-02 16:56:41( TIMEZONE : IST )
Biogen Pharmachem Industries Ltd has reported Standalone financial results for the period ended December 31, 2022.
Financial Results (Q3 FY2023) - QoQ Comparison
The company has reported total income of Rs. 0.3250 crores during the period ended December 31, 2022 as compared to Rs. 2.0501 crores during the period ended September 30, 2022.
The company has posted net profit / (loss) of Rs. 0.3013 crores for the period ended December 31, 2022 as against net profit / (loss) of Rs. 1.9413 crores for the period ended September 30, 2022.
The company has reported EPS of Rs. 0.0046 for the period ended December 31, 2022 as compared to Rs. 0.03 for the period ended September 30, 2022.
| Financials | Q3 FY2023 | Q2 FY2023 | % Change |
| Total Income | ₹0.3250 crs | ₹2.0501 crs |  -84.15% |
| Net Profit | ₹0.3013 crs | ₹1.9413 crs | -84.48% |
| EPS | ₹0.0046 | ₹0.03 | -84.67% |
Financial Results (Q3 FY2023) - YoY Comparison
The company has reported total income of Rs.0.3250 crores during the period ended December 31, 2022 as compared to Rs.0.0287 crores during the period ended December 31, 2021.
The company has posted net profit / (loss) of Rs.0.3013 crores for the period ended December 31, 2022 as against net profit / (loss) of Rs.0.0108 crores for the period ended December 31, 2021.
The company has reported EPS of Rs.0.0046 for the period ended December 31, 2022 as compared to Rs.0.0001 for the period ended December 31, 2021.
| Financials | Q3 FY2023 | Q3 FY2022 | % Change |
| Total Income | ₹0.3250 crs | ₹0.0287 crs |  1,032.40% |
| Net Profit | ₹0.3013 crs | ₹0.0108 crs | 2,689.81% |
| EPS | ₹0.0046 | ₹0.0001 | 4,500.00% |
Financial Results (9 Months Ended FY2023) - YoY Comparison
The company has reported total income of Rs.0.8383 crores during the 9 Months period ended December 31, 2022 as compared to Rs.2.3386 crores during the 9 Months period ended December 31, 2021.
The company has posted net profit / (loss) of Rs.0.6523 crores for the 9 Months period ended December 31, 2022 as against net profit / (loss) of Rs.0.2224 crores for the 9 Months period ended December 31, 2021.
The company has reported EPS of Rs.0.0099 for the 9 Months period ended December 31, 2022 as compared to Rs.0.0034 for the 9 Months period ended December 31, 2021.
| Financials | 9 Months Ended FY2023 | 9 Months Ended FY2022 | % Change |
| Total Income | ₹0.8383 crs | ₹2.3386 crs | -64.15% |
| Net Profit | ₹0.6523 crs | ₹0.2224 crs | 193.30% |
| EPS | ₹0.0099 | ₹0.0034 | 191.18% |
Shares of Biogen Pharmachem Industries Ltd was last trading in BSE at Rs. 0.79 as compared to the previous close of Rs. 0.80. The total number of shares traded during the day was 1492251 in over 2359 trades.
The stock hit an intraday high of Rs. 0.82 and intraday low of 0.79. The net turnover during the day was Rs. 1197085.00.
